HC Wainwright Has Bearish Estimate for AGIO FY2026 Earnings
Agios Pharmaceuticals, Inc. (NASDAQ:AGIO – Free Report) – Research analysts at HC Wainwright dropped their FY2026 EPS estimates for Agios Pharmaceuticals in a report issued on Monday, June 9th. HC Wainwright analyst E. Bodnar now forecasts that the biopharmaceutical company will post earnings of ($8.44) per share for the year, down from their previous estimate […]
